T-BOLT Trademark

Trademark Overview

On Monday, May 9, 2022, a trademark application was filed for T-BOLT with the United States Patent and Trademark Office. The USPTO has given the T-BOLT trademark a serial number of 97402105. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Wednesday, September 4, 2024. This trademark is owned by Crossbow Therapeutics, Inc.. The T-BOLT trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of cancer and immunological diseases; Medical and scientific research information in the field of cancer and immunological diseases; Pharmaceutical research and development; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development in the field of cancer and immunological diseases; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Scientific research for medical purposes in the area of cancerous diseases; Scientific research for medical purposes in the field of cancer and immunological d...
t-bolt

General Information

Serial Number97402105
Word MarkT-BOLT
Filing DateMonday, May 9, 2022
Status733 - FOURTH EXTENSION - GRANTED
Status DateWednesday, September 4, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 6, 2022

Trademark Statements

Pseudo MarkT BOLT
Goods and ServicesMedical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of cancer and immunological diseases; Medical and scientific research information in the field of cancer and immunological diseases; Pharmaceutical research and development; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development in the field of cancer and immunological diseases; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Scientific research for medical purposes in the area of cancerous diseases; Scientific research for medical purposes in the field of cancer and immunological diseases; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; Consulting services in the field of pharmaceutical research and development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, August 1, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCrossbow Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02138
Party NameCrossbow Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Monday, August 1, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 12, 2022NEW APPLICATION ENTERED
Monday, May 16, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 1, 2022ASSIGNED TO EXAMINER
Monday, August 1, 2022NON-FINAL ACTION WRITTEN
Monday, August 1, 2022NON-FINAL ACTION E-MAILED
Monday, August 1, 2022EXAMINERS AMENDMENT -WRITTEN
Monday, August 1, 2022EXAMINERS AMENDMENT E-MAILED
Monday, August 1, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, August 1, 2022EXAMINER'S AMENDMENT ENTERED
Monday, August 1, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 17, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 6, 2022PUBLISHED FOR OPPOSITION
Tuesday, September 6, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 1, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, May 1, 2023SOU EXTENSION 1 FILED
Monday, June 5, 2023ABANDONMENT - NO USE STATEMENT FILED
Monday, June 5, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Thursday, June 15, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, June 15, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, June 15, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, June 15, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, June 15, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, June 25, 2023TEAS PETITION TO REVIVE RECEIVED
Sunday, June 25, 2023PETITION TO REVIVE-GRANTED
Sunday, June 25, 2023SOU EXTENSION RECEIVED WITH TEAS PETITION
Monday, June 26, 2023NOTICE OF REVIVAL - E-MAILED
Monday, August 7, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, August 8, 2023SOU EXTENSION 1 GRANTED
Wednesday, August 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 11, 2023SOU TEAS EXTENSION RECEIVED
Monday, September 11, 2023SOU EXTENSION 2 FILED
Monday, September 11, 2023SOU EXTENSION 2 GRANTED
Wednesday, September 13, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 4, 2024ASSIGNED TO EXAMINER
Monday, March 4, 2024SOU TEAS EXTENSION RECEIVED
Monday, March 4, 2024SOU EXTENSION 3 FILED
Monday, March 4, 2024SOU EXTENSION 3 GRANTED
Wednesday, March 6, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 4, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, September 4, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 4, 2024SOU EXTENSION 4 GRANTED
Wednesday, September 4, 2024SOU EXTENSION 4 FILED

Related Keywords

bolt research scientific medical field cancer diseases information development immunological providing